Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank86
3Y CAGR+2.4%
5Y CAGR+133.8%
Year-over-Year Change
Total earnings after all expenses, taxes, and interest
3Y CAGR
+2.4%/yr
Annual compound
5Y CAGR
+133.8%/yr
Recent deceleration
Percentile
P86
Within normal range
vs 5Y Ago
69.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $98.09M | -38.5% |
| 2024 | $159.52M | +16.0% |
| 2023 | $137.54M | +50.5% |
| 2022 | $91.39M | +47.1% |
| 2021 | $62.12M | +4327.4% |
| 2020 | $1.40M | -97.1% |
| 2019 | $48.94M | +952.9% |
| 2018 | $-5.74M | -227.3% |
| 2017 | $4.51M | -57.2% |
| 2016 | $10.53M | - |